Predictive experiment-based multiscale models of angiogenesis in breast cancer
Predictive experiment-based multiscale models of angiogenesis in breast cancer
批准号:
7623361
负责人:
ALEKSANDER S. POPEL
金额:
$58.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-13 至 2013-12-31
关键词:
AbbreviationsAdvanced Malignant NeoplasmAngiogenesis InhibitorsAngiogenesis PathwayAnimal ModelArtsBasement membraneBioinformaticsBiologicalBiological AssayBiologyBlood VesselsBlood VolumeBlood capillariesBreast Cancer CellBreast Cancer ModelCancer cell lineCell CommunicationCellsCharacteristicsClinicalClinical DataClinical TrialsCommunitiesComputer SimulationContrast MediaCoupledDataDevelopmentDiagnosisDiagnostic Neoplasm StagingDiseaseDrug DesignDrug KineticsEndothelial CellsEngineeringEnzyme-Linked Immunosorbent AssayEpidermal Growth FactorEquationEquilibriumEstrogensExtracellular MatrixFatty acid glycerol estersFeedbackFemaleFibroblast Growth FactorGenerationsGoalsGreen Fluorescent ProteinsGrowthGrowth FactorHomeostasisHorseradish PeroxidaseHumanHypoxiaHypoxia Inducible FactorImageImmuneIndianaKnowledgeLaboratoriesLaser Scanning Confocal MicroscopyLaser Scanning MicroscopyLibrariesLigandsLinkMCF7 cellMagnetic ResonanceMagnetic Resonance ImagingMalignant NeoplasmsMammary NeoplasmsMammary glandMatrix MetalloproteinasesMeasurementMethodologyMethodsMiningModelingMolecularMolecular ModelsMonoclonal AntibodiesMusNatureNeoplasm MetastasisNeoplasms in Vascular TissueNeuropilinsNitric Oxide SynthaseOxygen measurement, partial pressure, arterialPC3 cell linePGF genePathogenesisPatientsPeptidesPharmaceutical PreparationsPharmacologic SubstancePhysiologicalPlacental Growth FactorPlatelet-Derived Growth FactorPlayPrimary NeoplasmProcessProcollagen-Proline DioxygenaseProgesterone ReceptorsProgression-Free SurvivalsProtein FragmentProteinsProteolysisProteomePublishingReactionResearchResponse ElementsRoleSignal TransductionSimulateSystems BiologyTestingTherapeuticTherapeutic procedureThrombospondin 1Tissue Inhibitor of MetalloproteinasesTissuesTranslatingTranslationsTumor AngiogenesisTumor stageUnited StatesUnited States Food and Drug AdministrationUniversitiesValidationVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth FactorsVascular PermeabilitiesVascular blood supplyWhole OrganismXenograft procedureabstractingangiogenesisantiangiogenesis therapybasecancer imagingcancer typecapillaryclinical applicationdesignenhanced green fluorescent proteinhuman diseaseimaging modalityin vivoin vivo Cellular and Molecular Imaging Centersinhibitor/antagonistinsightmagnetic resonance spectroscopic imagingmalignant breast neoplasmmembermolecular imagingmolecular modelingmulti-scale modelingneovascularnovel therapeuticsoptical imagingoverexpressionpharmacokinetic modelpublic health relevancereceptorred fluorescent proteinresearch studyresponsescale upsecond harmonicsimulationtooltumortumor progressionvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Project Summary/Abstract Tumors are angiogenesis-dependent as they require blood supply to grow and metastasize. Angiogenesis is regulated by a multitude of stimulators and inhibitors that maintain vascular homeostasis under physiological conditions. This angiogenic balance is tipped in favor of proangiogenic factors in cancer. The proangiogenic factors include many growth factors among which vascular endothelial growth factor (VEGF) plays a prominent role. Among endogenous antiangiogenic factors several whole proteins, e.g. thrombospondin-1, as well as protein fragments have been identified; most of the known fragments reside in the extracellular matrix. A quantitative understanding of how these factors interact to result in a growing vasculature and how to control this growth is presently lacking. To achieve a better understanding of these processes, the development of predictive experiment-based molecular-detailed multiscale computational models of tumor angiogenesis is necessary. This research will focus on breast cancer. The long-term goal of this project is to develop such models of the breast cancer angiogenesis physiome. The computational developments will be tightly coupled to state of the art breast cancer imaging at the molecular, cellular, microvascular, and tissue levels using animal models. The invasive human breast cancer cell line MDA-MB-231 and the less invasive human breast cancer cell line MCF-7 will be used to generate orthotopic xenografts in the mammary fat pad in female severe combined immune deficient (SCID) mice. The measurements will include the characterization and localization of receptor and ligand expression at the different stages of tumor development; temporal and spatial development of hypoxia and microvasculature in growing tumor; and functional characteristics of the tumor microvasculature such as blood volume and vascular permeability, and the extracellular matrix. Part of these data will serve as input to the computational models whereas other data will serve as a means for their validation. The models will be extended to human disease. The research will contribute to a better fundamental understanding of the tumor vascular biology and to the design of novel therapeutics and quantitative interpretation of clinical data. The synergistic combination of computational and experimental studies should provide significant insights into the nature of the disease.
PUBLIC HEALTH RELEVANCE: Narrative Breast cancer is the most commonly diagnosed female malignancy in the United States. Angiogenesis or neovascular growth plays a key role in breast cancer development, invasion and metastasis. Using synergistic combination of computational and experimental methods, the project will provide a better quantitative understanding of angiogenesis stimulation and inhibition, leading to translation of fundamental knowledge into novel therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioinformatic analysis of molecular networks in peripheral artery disease
-
批准号:8909175
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2014
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Systems Biology of Angiogenesis in Peripheral Arterial Disease
-
批准号:7845860
-
项目类别:
-
资助金额:$79.52万
-
财政年份:2010
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Systems Biology of Angiogenesis in Peripheral Arterial Disease
-
批准号:10368099
-
项目类别:
-
资助金额:$81.24万
-
财政年份:2010
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Systems Biology of Angiogenesis in Peripheral Arterial Disease
-
批准号:9908148
-
项目类别:
-
资助金额:$81.24万
-
财政年份:2010
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Systems Biology of Angiogenesis in Peripheral Arterial Disease
-
批准号:8451397
-
项目类别:
-
资助金额:$77.91万
-
财政年份:2010
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Systems Biology of Angiogenesis in Peripheral Arterial Disease
-
批准号:8134170
-
项目类别:
-
资助金额:$5.1万
-
财政年份:2010
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Systems Biology of Angiogenesis in Peripheral Arterial Disease
-
批准号:8060544
-
项目类别:
-
资助金额:$92.68万
-
财政年份:2010
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Systems Biology of Angiogenesis in Peripheral Arterial Disease
-
批准号:8887403
-
项目类别:
-
资助金额:$79.14万
-
财政年份:2010
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Systems Biology of Angiogenesis in Peripheral Arterial Disease
-
批准号:8253755
-
项目类别:
-
资助金额:$93.05万
-
财政年份:2010
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Systems Biology of Angiogenesis in Peripheral Arterial Disease
-
批准号:8644855
-
项目类别:
-
资助金额:$76.71万
-
财政年份:2010
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Systems Biology of Angiogenesis in Peripheral Arterial Disease
-
批准号:9251840
-
项目类别:
-
资助金额:$78.45万
-
财政年份:2010
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Predictive experiment-based multiscale models of angiogenesis in breast cancer
-
批准号:8403681
-
项目类别:
-
资助金额:$53.44万
-
财政年份:2009
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
-
批准号:10238909
-
项目类别:
-
资助金额:$52.78万
-
财政年份:2009
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Predictive experiment-based multiscale models of angiogenesis in breast cancer
-
批准号:8009891
-
项目类别:
-
资助金额:$57.37万
-
财政年份:2009
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Predictive experiment-based multiscale models of angiogenesis in breast cancer
-
批准号:9321588
-
项目类别:
-
资助金额:$52.61万
-
财政年份:2009
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Exploration and development of antiangiogenic peptides for breast cancer
-
批准号:7779389
-
项目类别:
-
资助金额:$18.04万
-
财政年份:2009
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Predictive experiment-based multiscale models of angiogenesis in breast cancer
-
批准号:8756923
-
项目类别:
-
资助金额:$52.61万
-
财政年份:2009
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
-
批准号:10684121
-
项目类别:
-
资助金额:$52.78万
-
财政年份:2009
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
-
批准号:10476999
-
项目类别:
-
资助金额:$51.72万
-
财政年份:2009
-
负责人:ALEKSANDER S. POPEL
-
依托单位:
Predictive experiment-based multiscale models of angiogenesis in breast cancer
-
批准号:8917130
-
项目类别:
-
资助金额:$52.61万
-
财政年份:2009
-
负责人:ALEKSANDER S. POPEL
-
依托单位: